| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Perry Michael S is a Director at Armata Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $14.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 185,000 | $29.41 | $5,440,000.00 | -54.1% | |
| Mar 22, 2018 | ARMP Armata Pharmaceuticals, Inc. | Director | Buy | 292,592 | $0.68 | $200,002.00 | +62.0% |